Perrone, V.; Usala, M.; Veronesi, C.; Cappuccilli, M.; Degli Esposti, L.
Drug Utilization of Rifaximin-α in Patients with Hepatic Encephalopathy: Evidence from Real Clinical Practice in Italy. Medicina 2025, 61, 221.
https://doi.org/10.3390/medicina61020221
AMA Style
Perrone V, Usala M, Veronesi C, Cappuccilli M, Degli Esposti L.
Drug Utilization of Rifaximin-α in Patients with Hepatic Encephalopathy: Evidence from Real Clinical Practice in Italy. Medicina. 2025; 61(2):221.
https://doi.org/10.3390/medicina61020221
Chicago/Turabian Style
Perrone, Valentina, Marcello Usala, Chiara Veronesi, Maria Cappuccilli, and Luca Degli Esposti.
2025. "Drug Utilization of Rifaximin-α in Patients with Hepatic Encephalopathy: Evidence from Real Clinical Practice in Italy" Medicina 61, no. 2: 221.
https://doi.org/10.3390/medicina61020221
APA Style
Perrone, V., Usala, M., Veronesi, C., Cappuccilli, M., & Degli Esposti, L.
(2025). Drug Utilization of Rifaximin-α in Patients with Hepatic Encephalopathy: Evidence from Real Clinical Practice in Italy. Medicina, 61(2), 221.
https://doi.org/10.3390/medicina61020221